Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells
Article in Journal for ImmunoTherapy of Cancer (May 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (May 2024)
Article in PLOS Pathogens (December 2020)
Article in Vaccine (June 2017)